← Eichor
Condition: Biochemical Recurrence Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Biochemical Recurrence

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Phase 2 · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT05753566Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence
Phase N/A · 1 location(s) · University of Milano Bicocca · NCT06941363PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05022914Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
Phase 3 · 5 location(s) · Stefan Carlsson · NCT04794777PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
Phase 3 · 13 location(s) · University Medical Center Groningen · NCT04642027Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro
Phase 3 · 1 location(s) · Samsung Medical Center · NCT07500701A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-lig
Phase N/A · 2 location(s) · Technical University of Munich · NCT06859203Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Phase 1 · 12 location(s) · Vir Biotechnology, Inc. · NCT05997615Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
Phase 1 · 1 location(s) · University Hospital Tuebingen · NCT05646550Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
NA · 3 location(s) · Lund University Hospital · NCT04858880A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate
Phase 3 · 342 location(s) · AstraZeneca · NCT06952803Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20
NA · 4 location(s) · CHU de Quebec-Universite Laval · NCT07483658PSMA-RLT in Biochemically Recurrent PCa
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06220188Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06657131Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recu
Phase 2 · 1 location(s) · St Vincent's Hospital, Sydney · NCT06907641Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
Phase 3 · 17 location(s) · Instituto de Investigación en Oncología Radioterápica - Fund · NCT05781217Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
NA · 13 location(s) · Jules Bordet Institute · NCT06523634Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of
Phase 2 · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06305832Long-term Better Than Short-term ADT With Salvage RT
Phase 2/Phase 3 · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04242017PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Phase 2 · 1 location(s) · Hoag Memorial Hospital Presbyterian · NCT04700332Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cance
NA · 1 location(s) · Sinotau Pharmaceutical Group · NCT07115277Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy
NA · 2 location(s) · Asan Medical Center · NCT03920033Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · 342 location(s) · ECOG-ACRIN Cancer Research Group · NCT0442321168Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
Phase 3 · 8 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT05847348PROCARE - PROstate Cancer Real World Evidence Registry
Phase N/A · 53 location(s) · UroTrials Company (GmbH) · NCT06835218
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.